Finance

Lists
Why is CRBU down 4.36%?
Dive Deeper
CRBU:NASDAQ
Caribou Biosciences Inc
$ 0.46
-4.36%
(-0.021) 1D
$ 0.46
+0.56% (+0.0026)
After hours
Closed: 10-р сарын 9, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBU...
Open
$ 0.46
High
$ 0.52
Low
$ 0.44
Mkt. cap
49.46 сая
Avg. vol.
3.11 сая
Volume
9.74 сая
52-wk high
$ 3.53
52-wk low
$ 0.44
EPS
-$ 1.08
Beta
2.31
Shares outstanding
107.21 сая
No. of employees
97
Open
$ 0.46
High
$ 0.52
Low
$ 0.44
Mkt. cap
49.46 сая
Avg. vol.
3.11 сая
Volume
9.74 сая
52-wk high
$ 3.53
52-wk low
$ 0.44
EPS
-$ 1.08
Beta
2.31
Shares outstanding
107.21 сая
No. of employees
97
News stories
From web sources and news partners
About Caribou Biosciences Inc
CEO-
Employees97
Founded2011 оны 1-р сарын 1
HeadquartersBerkeley, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Websitecariboubio.com
Analyst ratings
Based on 6 analysts giving stock ratings to CRBU in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CRBU in the last 3 months.
Highest
Current $ 0.46
$ 8.00 (+1,638.37%)
Average
$ 3.75 (+714.86%)
Lowest
$ 1.00 (+117.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
10/08/2026
Daina Graybosch
Leerink Partners
Hold
Downgraded
$ 1.00
+117.3%
10/07/2026
Luca Issi
RBC Capital
Hold
Downgraded
$ 1.00
+117.3%
10/06/2026
Leah R. Cann
Brookline Capital Markets
Hold
Downgraded
-
-
10/06/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
$ 5.00
+986.5%
08/14/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$ 8.00
+1,638.4%
08/13/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$ 13.00
+2,724.9%
03/09/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
$ 7.00
+1,421.1%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$ 4.00
+769.2%
03/06/2026
William Maughan
Clear Street
Buy
Maintained
$ 13.00
+2,724.9%
03/06/2026
Last report
2026 оны 8-р сарын 13
Fiscal period
Q2 2026
-$ 0.24 / -$ 0.31
+21.74%beat
Revenue / Est. (USD)
1.50 сая / 2.25 сая
-33.25%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.20 сая
3.94 сая
2.40 сая
1.50 сая
Cost of goods sold
22.40 сая
23.82 сая
20.61 сая
18.94 сая
Cost of revenue
22.40 сая
23.82 сая
20.61 сая
18.94 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.20 сая
8.58 сая
8.07 сая
7.90 сая
Operating expense
9.20 сая
8.58 сая
8.07 сая
7.90 сая
Total operating expenses
31.60 сая
32.39 сая
28.68 сая
26.84 сая
Operating income
-29.40 сая
-28.45 сая
-26.28 сая
-25.34 сая
Other non operating income
-
42.00 мян
-
-
EBT including unusual items
-27.55 сая
-27.04 сая
-25.08 сая
-24.28 сая
EBT excluding unusual items
-27.55 сая
-27.04 сая
-25.08 сая
-24.28 сая
Income tax expense
-
-550.00 мян
-
-
Effective tax rate
-
2.03%
-
-
Other operating expenses
-
-
-
-
Net income
-27.55 сая
-26.49 сая
-25.08 сая
-24.28 сая
Net profit margin
-1,253.32%
-672.11%
-1,046.52%
-1,619.88%
Earnings per share
-
-
-0.26
-0.24
Interest and investment income
1.85 сая
1.37 сая
1.20 сая
1.06 сая
Interest expense
-
-
-
-
Net interest expenses
1.85 сая
1.37 сая
1.20 сая
1.06 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.77 сая
-27.77 сая
-25.63 сая
-24.71 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс